Profile data is unavailable for this security.
About the company
Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.
- Revenue in AUD (TTM)4.90m
- Net income in AUD-6.94m
- Incorporated1994
- Employees6.00
- LocationImmuron LtdL 3 62 Lygon StMELBOURNE 3053AustraliaAUS
- Phone+61 39824-5254
- Fax+61 39822-7735
- Websitehttps://www.immuron.com.au
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hydration Pharmaceuticals Co Ltd | 14.92m | -11.81m | 5.18m | -- | -- | -- | -- | 0.3474 | -0.0472 | -0.0472 | 0.056 | -0.0139 | 1.49 | 1.56 | 6.38 | -- | -117.74 | -79.98 | -251.39 | -111.57 | 56.00 | 48.73 | -79.18 | -99.53 | 0.8282 | -4.39 | 2.42 | -- | 10.34 | 19.27 | 23.61 | -- | -- | -- |
| Nutritional Growth Solutions Ltd | 4.17m | -4.14m | 5.82m | -- | -- | -- | -- | 1.40 | -0.1712 | -0.1712 | 0.1722 | -0.0877 | 2.08 | 2.36 | 33.46 | -- | -206.84 | -- | -- | -- | 22.36 | 42.47 | -99.30 | -152.30 | 0.0943 | -57.50 | -- | -- | 1.26 | 41.61 | 31.91 | -- | -- | -- |
| TrivarX Ltd | 893.31k | -1.43m | 6.86m | 4.00 | -- | 0.6211 | -- | 7.67 | -0.0045 | -0.0045 | 0.0027 | 0.0242 | 0.0935 | -- | -- | -- | -15.02 | -37.57 | -17.67 | -43.65 | 100.00 | 92.56 | -160.59 | -446.23 | -- | -105.74 | 0.0016 | -- | -6.99 | -26.39 | 53.28 | -- | 17.61 | -- |
| Epsilon Healthcare Ltd | 7.21m | -5.93m | 7.21m | -- | -- | 0.7868 | -- | 0.9994 | -0.0198 | -0.0198 | 0.0241 | 0.0305 | 0.3839 | 17.94 | 2.73 | -- | -31.54 | -35.68 | -46.30 | -41.11 | 37.99 | 26.88 | -82.17 | -197.56 | 0.5237 | -9.28 | 0.2329 | -- | 29.36 | 30.99 | -43.77 | -- | 8.14 | -- |
| Firebrick Pharma Ltd | 14.52k | -1.18m | 10.93m | -- | -- | 4.33 | -- | 752.45 | -0.0066 | -0.0066 | 0.00008 | 0.012 | 0.0054 | -- | 0.0267 | -- | -43.64 | -98.70 | -51.22 | -109.33 | -156.89 | -- | -8,098.28 | -80,697.28 | 6.36 | -- | 0.00 | -- | 1,649.40 | -- | 82.71 | -- | -- | -- |
| Anatara Lifesciences Ltd | 0.00 | -1.45m | 11.19m | -- | -- | 8.12 | -- | -- | -0.0098 | -0.0098 | 0.00 | 0.0071 | 0.00 | -- | -- | -- | -93.91 | -76.37 | -126.61 | -88.90 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 28.27 | -- | -- | -- |
| Argent BioPharma Ltd | 891.08k | -17.53m | 12.48m | -- | -- | -- | -- | 14.01 | -0.5116 | -0.5116 | 0.0241 | -0.1138 | 0.0858 | 0.6144 | 1.77 | -- | -168.97 | -129.61 | -- | -254.28 | 22.86 | -27.15 | -1,969.34 | -667.99 | 0.1532 | -37.54 | -- | -- | -73.70 | 6.31 | 15.81 | -- | -17.96 | -- |
| Acrux Ltd | 8.10m | -5.80m | 13.37m | 43.00 | -- | 4.08 | -- | 1.65 | -0.02 | -0.02 | 0.028 | 0.0113 | 0.728 | -- | 2.61 | -- | -52.14 | -45.05 | -71.89 | -54.04 | 51.14 | -- | -71.62 | -114.01 | -- | -- | 0.5307 | -- | -32.11 | 8.91 | -659.16 | -- | -6.20 | -- |
| Althea Group Holdings Ltd | 30.37m | -32.06m | 16.21m | -- | -- | 51.78 | -- | 0.5338 | -0.0858 | -0.0858 | 0.0808 | 0.0008 | 0.8438 | 2.34 | 7.03 | -- | -89.06 | -37.78 | -167.97 | -47.13 | 60.70 | 53.83 | -105.54 | -94.47 | 0.4086 | -4.08 | 0.9466 | -- | 20.87 | 99.01 | -133.57 | -- | -25.27 | -- |
| Immuron Ltd | 4.90m | -6.94m | 17.19m | 6.00 | -- | 1.35 | -- | 3.51 | -0.0304 | -0.0304 | 0.0215 | 0.0557 | 0.2612 | 1.29 | 5.43 | -- | -36.96 | -27.01 | -42.53 | -29.33 | 68.06 | 74.23 | -141.49 | -245.53 | 4.87 | -3.03 | 0.0032 | -- | 171.67 | 15.48 | -83.20 | -- | -37.22 | -- |
| Calmer Co International Ltd | 4.26m | -3.73m | 17.64m | -- | -- | -- | -- | 4.14 | -0.0035 | -0.0035 | 0.0038 | -0.0003 | 1.13 | 2.01 | 9.14 | -- | -98.45 | -119.20 | -395.42 | -195.49 | 49.62 | 39.01 | -87.42 | -219.69 | 0.5607 | -12.30 | 1.27 | -- | 138.92 | 87.79 | 28.91 | -- | -20.42 | -- |
| Nyrada Inc | 3.40m | -1.39m | 22.01m | -- | -- | 3.79 | -- | 6.47 | -0.0081 | -0.0081 | 0.0209 | 0.0277 | 0.6147 | -- | -- | -- | -25.13 | -53.28 | -29.75 | -62.52 | -- | -- | -40.89 | -236.15 | -- | -- | 0.00 | -- | 115.55 | 46.42 | 82.12 | -- | -- | -- |
| Oncosil Medical Ltd | 583.20k | -11.91m | 31.32m | 2.00 | -- | 4.92 | -- | 53.70 | -0.0054 | -0.0054 | 0.0003 | 0.0014 | 0.0641 | -- | 3.12 | -- | -130.97 | -67.66 | -162.31 | -77.45 | -158.87 | -- | -2,042.81 | -768.23 | -- | -- | 0.0147 | -- | 35.54 | -31.37 | -5.03 | -- | 67.76 | -- |
